ATLASBraveheart Bio (BRVE) earnings date: Dec 8, 2026
Braveheart Bio (BRVE) reports earnings for the quarter ended Sep 30, 2026 on Tue, Dec 8, 2026. Analysts expect EPS of -$0.91.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BRVE
| Last price | $20.90 (-2.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
These figures come from the same calibrated model and valuation as the Braveheart Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Braveheart Bio reports on Dec 8, 2026. One email the day before, with ATLAS’s read on Braveheart Bio. You can switch it off at any time.
Alert me before BRVE reportsFree to start. Creating an account takes under a minute.
Notify me when Braveheart Bio reports
Track BRVE free Add Braveheart Bio to a free ATLAS watchlist and see its next report date in one place.
BRVE earnings at a glance
| Next report (confirmed) | Tue, Dec 8, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.91 |
| Last report | Sep 8, 2026 · Miss |
| Average EPS surprise | -904.0% |
| Sector | Healthcare · Biotechnology |
Braveheart Bio earnings history: last 1 reports
Braveheart Bio last reported on Sep 8, 2026: EPS of -$2.51 against an estimate of -$0.25 (-904.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 8, 2026 | -$0.25 | -$2.51 | -904.0% | Miss | +8.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BRVE
See the fair value, the probability range and the earnings history of Braveheart Bio on its ATLAS page.
Braveheart Bio (BRVE) stock analysisPlans from €3.99 a month.
Braveheart Bio earnings: frequently asked questions
When does Braveheart Bio (BRVE) report earnings?
Braveheart Bio is scheduled to report on Tuesday, December 8, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BRVE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.91 per share (USD). Estimates can change before the report.
Did Braveheart Bio beat earnings estimates last quarter?
Braveheart Bio last reported on Sep 8, 2026: EPS of -$2.51 against an estimate of -$0.25 (-904.0% surprise), a miss.
How much does BRVE usually move in a day?
On a normal trading day the ATLAS model puts BRVE’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Dec 8, 2026
Educational information, not investment advice. Disclaimer